Facebook Pixel Are BioStartUps in a Funding/Innovation Rut? | Bio Spectrum - business - Lee esta historia en Magzter.com
Vuélvete ilimitado con Magzter GOLD

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99
 
$74.99/Año

Intentar ORO - Gratis

Are BioStartUps in a Funding/Innovation Rut?

Bio Spectrum

|

September 2025

At the BioStartUps Founders & Investors Forum 2025, held on August 1, 2025 at the CIDCO Exhibition Centre in Vashi, Navi Mumbai, biotech industry stalwarts deliberated on the country's innovation and startup ecosystem.

- Sanjiv Das

Are BioStartUps in a Funding/Innovation Rut?

While exceptional support to biotech startups is already being provided by bioincubators across various states in the country, there is a need to establish incubators in places where the surrounding ecosystem can further support the startup growth. Mechanisms are also required to be developed for industry-academia collaboration to purely focus on commercialisation, along with establishment of strategic funds for biotech ventures to succeed. Experts at the forum also highlighted the disparities between research institutions and industrial zones in terms of infrastructure and talent access, and how these elements can be co-located to create a win-win situation for the Indian biotech sector. Moreover, a few industry experts observed that startups need not just increased, steady inflow of investments but also idea validation that actually addresses real problems.

With India's bioeconomy projected to reach $300 billion by 2030, the role of the biotechnology startup community, supported by the bioincubators, is particularly instrumental. While Institutions like the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) have nurtured the evolution of biotech startups, it is absolutely essential to address challenges that could hinder the progress of these startups.

For instance, while early-stage investors are willing to fund and nurture the biotech startups, the lack of growth-stage capital in India is a major hurdle. Without larger funding pools, we risk losing promising companies to overseas markets through acquisitions or relocations. On the other hand, we see a lot of investors-based activity taking place only in Tier-I cities, while innovations emerging from startups based out of Tier-II or III cities are missing out on opportunities.

MÁS HISTORIAS DE Bio Spectrum

Bio Spectrum

Bio Spectrum

Can India's CDMOS Lead the Next Biopharma Wave?

India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).

time to read

8 mins

March 2026

Bio Spectrum

Bio Spectrum

Telangana turns catalyst for innovation

Telangana is at a pivotal moment in its journey as a global life sciences hub.

time to read

6 mins

March 2026

Bio Spectrum

Bio Spectrum

Is AI the New Weapon in the Fight to End TB?

A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).

time to read

2 mins

March 2026

Bio Spectrum

Bio Spectrum

ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India

US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy

Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"

Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer

Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Haleon ropes in Kedar Lele as President for India Subcontinent

Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Centre revises Startup Recognition Framework to strengthen Startup India Action Plan

The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"

In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.

time to read

5 mins

March 2026

Listen

Translate

Share

-
+

Change font size